FGFR3 and urinary bladder cancer: In particular, tumor protein 53 (TP53), fibroblast growth factor receptor-3 (FGFR3) mutations, and genes involved in the phosphatidylinositol-3-OH kinase (Pl3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway were found to be associated with the prognosis of bladder cancer [5].